GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jacobio Pharmaceuticals Group Co Ltd (STU:77V) » Definitions » Gross-Profit-to-Asset %

Jacobio Pharmaceuticals Group Co (STU:77V) Gross-Profit-to-Asset % : 0.00% (As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Jacobio Pharmaceuticals Group Co Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Jacobio Pharmaceuticals Group Co's annualized Gross Profit for the quarter that ended in Jun. 2024 was €0.00 Mil. Jacobio Pharmaceuticals Group Co's average Total Assets over the quarter that ended in Jun. 2024 was €177.84 Mil. Therefore, Jacobio Pharmaceuticals Group Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Jun. 2024 was 0.00%.


Jacobio Pharmaceuticals Group Co Gross-Profit-to-Asset % Historical Data

The historical data trend for Jacobio Pharmaceuticals Group Co's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jacobio Pharmaceuticals Group Co Gross-Profit-to-Asset % Chart

Jacobio Pharmaceuticals Group Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Gross-Profit-to-Asset %
Get a 7-Day Free Trial 39.51 0.75 0.76 0.21 11.17

Jacobio Pharmaceuticals Group Co Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.47 0.30 0.10 - 23.59

Competitive Comparison of Jacobio Pharmaceuticals Group Co's Gross-Profit-to-Asset %

For the Biotechnology subindustry, Jacobio Pharmaceuticals Group Co's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jacobio Pharmaceuticals Group Co's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Jacobio Pharmaceuticals Group Co's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Jacobio Pharmaceuticals Group Co's Gross-Profit-to-Asset % falls into.


;
;

Jacobio Pharmaceuticals Group Co Gross-Profit-to-Asset % Calculation

Jacobio Pharmaceuticals Group Co's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=0.411/( (213.214+187.566)/ 2 )
=0.411/200.39
=0.21 %

Jacobio Pharmaceuticals Group Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Jun. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Jun. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Jun. 2024 ))/ count )
=0/( (187.566+168.106)/ 2 )
=0/177.836
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Jun. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Jacobio Pharmaceuticals Group Co Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Jacobio Pharmaceuticals Group Co's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Jacobio Pharmaceuticals Group Co Business Description

Traded in Other Exchanges
Address
No. 88, Kechuang 6th Street, Building F2, Beijing Economic-Technological Development Area, Beijing, CHN
Jacobio Pharmaceuticals Group Co Ltd is a clinical-stage pharmaceutical company focusing on the in-house discovery and development of innovative oncology therapies.

Jacobio Pharmaceuticals Group Co Headlines

No Headlines